Relevance of cfMethyl-Seq random-split four-cancer detection to "Select a plasma ctDNA methylation detection workflow"
- Use case
- Select a plasma ctDNA methylation detection workflow
- Assessed by
- cfMethyl-Seq random-split four-cancer detection
- Relevance
- Direct evidence
- Endpoint
- All-stage cancer-detection sensitivity (95% CI) at a declared specificity for cfMethyl-Seq on a repeated random 25% test split
A repeated-split cross-validated sensitivity/specificity figure at a declared specificity directly measures plasma cfDNA methylation cancer-detection performance, the declared endpoint.
1 reviewed evaluation
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
30 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
Citation locations2 values
| cfMethyl-Seq cancer detection primary paper amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2022 version of record, corrected competing-interest disclosure in 2024 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Citation locations2 values
| cfMethyl-Seq author correction amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024-05-01 correction | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| cfMethyl-Seq cancer detection primary paper amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2022 version of record, corrected competing-interest disclosure in 2024 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Constraints2 values
| cfMethyl-Seq author correction amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024-05-01 correction | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint All-stage cancer-detection sensitivity (95% CI) at a declared specificity for cfMethyl-Seq on a repeated random 25% test split Context-only references | cfMethyl-Seq cancer detection primary paper amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2022 version of record, corrected competing-interest disclosure in 2024 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Endpoint All-stage cancer-detection sensitivity (95% CI) at a declared specificity for cfMethyl-Seq on a repeated random 25% test split Context-only references | cfMethyl-Seq author correction amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024-05-01 correction | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:amp-protocol-cfmethyl-randomsplit-detection Context-only references | cfMethyl-Seq cancer detection primary paper amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2022 version of record, corrected competing-interest disclosure in 2024 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
| Claimed field links:assessed_by:amp-protocol-cfmethyl-randomsplit-detection Context-only references | cfMethyl-Seq author correction amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024-05-01 correction | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations3 values
| cfMethyl-Seq cancer detection primary paper amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2022 version of record, corrected competing-interest disclosure in 2024 | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Limitations3 values
| cfMethyl-Seq author correction amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/ Shared locator for this statement’s cited sources; not a separate locator for each citation. Version: 2024-05-01 correction | not individually reviewed No individual claim review recorded Audit detailsField: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
2 source records and release history
- cfMethyl-Seq cancer detection primary paper · Original source · 2022 version of record, corrected competing-interest disclosure in 2024
- cfMethyl-Seq author correction · Original source · 2024-05-01 correction
Technical metadata and extraction receipts
Stable ID: use-case-mapping-amp-20261007-issue16
- field
- links:assessed_by:amp-protocol-cfmethyl-randomsplit-detection
- value
- amp-protocol-cfmethyl-randomsplit-detection
- relevance
- direct
- endpoint
- All-stage cancer-detection sensitivity (95% CI) at a declared specificity for cfMethyl-Seq on a repeated random 25% test split
- rationale
- A repeated-split cross-validated sensitivity/specificity figure at a declared specificity directly measures plasma cfDNA methylation cancer-detection performance, the declared endpoint.
- constraints
- Inspect every linked evaluation's source locator and preserved conflicts before citing a result.; Do not combine this mapping's evaluations with any other protocol's results.
- limitations
- No foundation-model comparison; No prospective screening benefit; No independent reproduction
- revision
- 1
- reason
- Add Codex-checked primary-source protocol evidence from the bounded AMP intake (rewire.it#365).
- citation locators
- source id: amp-source-cfmethyl; locator: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; source id: amp-source-cfmethyl-correction; locator: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- source locator
- amp-source-cfmethyl: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/; amp-source-cfmethyl-correction: See clinical/claims.csv and clinical/sources.md in data/omics/use-case-coverage-amp-20261007/
- review
- method: automated-source-review; reviewer: codex; claude-sonnet; reviewer note: Claude Sonnet AMP-integration worker, bounded transcription of Codex-checked primary values; independently reviewed by Codex (workbench/amp-supervision/primary-review.md, integration-review-corrections.md); reviewed at: 2026-10-07T13:38:59Z; note: Bounded primary-source transcription, independently Codex-checked. No new model execution, independent experimental reproduction, qualified human scientific review or clinical validation.
- reviewed evaluations
- amp-eval-cfmethyl-allstage-sensitivity
- pins
- record id: amp-eval-cfmethyl-allstage-sensitivity; fields: status; links; attributes.origin; attributes.comparison; sha256: b169760fcb27ba474469407d590f9316d8685df23fb4a4284fa728ba308192d7; record id: amp-protocol-cfmethyl-randomsplit-detection; fields: status; name; description; facets; source_ids; links; attributes; sha256: aa59aff860d0c5e13ccc7ed06b28a880ae42aa01a780e950aa2746239122ea64; record id: amp-result-cfmethyl-allstage-sensitivity; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: ccfdcb0f53de76382cba4ab2123d1cd7f742a52ed83bf21bd404d955d5ba910c; record id: amp-source-cfmethyl; fields: status; attributes.artifact_sha256; sha256: 59afebd3354186794d6cc1599490e86d35ff81a9de3e9131599ed12cd17998a1; record id: amp-source-cfmethyl-correction; fields: status; attributes.artifact_sha256; sha256: 0037edee085d6913f3a41a04bdb3f717e24684f27dd7c2bbe20015ba892e1983; record id: use-case-plasma-ctdna-methylation; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 4d9542463e1400d5d9701c7f52859a23e4c78804cbda1477663445f945e22429